Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12426
PUT
Vanda Pharmaceuticals
VNDA
$302M
| $127K | ﹤0.01% |
20,700
-39,800
| -66% | -$260K |
|
12427
CALL
MacroGenics
MGNX
$257M
| $127K | ﹤0.01% |
27,400
-30,400
| -53% | -$115K |
|
|
TWO
12428
PUT
DELISTED
Two Harbors Investment
TWO
| $127K | ﹤0.01% |
10,200
-3,000
| -23% | -$35.9K |
|
12429
PUT
Mizuho Financial
MFG
$135B
| $126K | ﹤0.01% |
13,200
-100
| -0.8% | -$898 |
|
|
FERA
12430
Fifth Era Acquisition Corp I
FERA
$329M
| $126K | ﹤0.01% |
12,135
-291,745
| -96% | -$3.03M |
|
12431
CALL
BTCS Inc
BTCS
$67.2M
| $126K | ﹤0.01% |
113,500
-35,000
| -24% | -$56.4K |
|
|
ADBG
12432
PUT
Leverage Shares 2X Long ADBE Daily ETF
ADBG
$36.1M
| $126K | ﹤0.01% |
42,100
+18,900
| +81% | +$79.9K |
|
12433
PUT
Goldgroup Mining
GORO
$477M
| $126K | ﹤0.01% |
24,975
-12,375
| -33% | -$67.6K |
|
12434
PUT
Yext
YEXT
$632M
| $126K | ﹤0.01% |
26,900
-33,400
| -55% | -$130K |
|
12435
CALL
FTC Solar
FTCI
$34.9M
| $125K | ﹤0.01% |
+24,700
| New | +$114K |
|
12436
NextPlat
NXPL
$24.4M
| $125K | ﹤0.01% |
+18,582
| New | +$115K |
|
|
NNDM
12437
PUT
Nano Dimension
NNDM
$323M
| $125K | ﹤0.01% |
86,500
+55,700
| +181% | +$91K |
|
|
RKLZ
12438
Defiance Daily Target 2x Short RKLB ETF
RKLZ
$23.4M
| $125K | ﹤0.01% |
9,936
+6,506
| +190% | +$265K |
|
|
SIND
12439
Sinda Ltd
SIND
$2.29B
| $125K | ﹤0.01% |
+10,386
| New | +$125K |
|
12440
Arts-Way Manufacturing Co
ARTW
$15.4M
| $125K | ﹤0.01% |
47,384
+34,839
| +278% | +$90.8K |
|
12441
CALL
Fulcrum Therapeutics
FULC
$288M
| $124K | ﹤0.01% |
34,000
+13,000
| +62% | +$79.1K |
|
|
PVL
12442
CALL
Permianville Royalty Trust
PVL
$62M
| $124K | ﹤0.01% |
73,600
-11,300
| -13% | -$21.1K |
|
12443
CALL
Gevo
GEVO
$388M
| $124K | ﹤0.01% |
82,800
-66,300
| -44% | -$117K |
|
|
ODYS
12444
Odysight.ai Inc
ODYS
$55.6M
| $124K | ﹤0.01% |
29,738
+18,214
| +158% | +$88.6K |
|
|
DRDB
12445
Roman DBDR Acquisition Corp II
DRDB
$327M
| $124K | ﹤0.01% |
+11,719
| New | +$123K |
|
|
LOT
12446
Lotus Technology
LOT
$634M
| $123K | ﹤0.01% |
105,517
+62,630
| +146% | +$79.8K |
|
12447
UNIFI
UFI
$125M
| $123K | ﹤0.01% |
25,911
-26,154
| -50% | -$104K |
|
12448
Xperi
XPER
$274M
| $123K | ﹤0.01% |
+14,938
| New | +$108K |
|
12449
PUT
Ambev
ABEV
$46.6B
| $123K | ﹤0.01% |
39,100
+2,500
| +7% | +$7.82K |
|
|
ELVA
12450
Electrovaya
ELVA
$307M
| $123K | ﹤0.01% |
11,671
-145,116
| -93% | -$1.44M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.